The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030.
<h4>Background</h4>Onchocerciasis ("river blindness") can cause severe morbidity, including vision loss and various skin manifestations, and is targeted for elimination using ivermectin mass drug administration (MDA). We calculated the number of people with Onchocerca volvulus...
Enregistré dans:
Auteurs principaux: | Natalie V S Vinkeles Melchers, Wilma A Stolk, Welmoed van Loon, Belén Pedrique, Roel Bakker, Michele E Murdoch, Sake J de Vlas, Luc E Coffeng |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b513b8d560024ee0a8ebb56d338e43fc |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?
par: Natalie V S Vinkeles Melchers, et autres
Publié: (2021) -
African Programme For Onchocerciasis Control 1995-2015: model-estimated health impact and cost.
par: Luc E Coffeng, et autres
Publié: (2013) -
Sustainable control of onchocerciasis: ocular pathology in onchocerciasis patients treated annually with ivermectin for 23 years: a cohort study.
par: Méba Banla, et autres
Publié: (2014) -
Predicting the environmental suitability for onchocerciasis in Africa as an aid to elimination planning.
par: Elizabeth A Cromwell, et autres
Publié: (2021) -
Ocular onchocerciasis: current management and future prospects
par: Babalola OE
Publié: (2011)